(Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | (FY)Mar 31, 2022 | (Q4)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -230.80%-320.65K | 23.96%-152.31K | 297.35%441.05K | 64.01%-302.87K | 150.78%217.86K | -438.13%-96.93K | 49.77%-200.3K | -428.21%-223.49K | 33.78%-841.41K | -163.84%-429.03K |
Net income from continuing operations | -884.58%-1.21M | -32.07%-459.1K | 141.95%154.71K | -13.38%-2.27M | -26.17%-1.43M | -13.59%-122.73K | 31.73%-347.61K | -46.97%-368.76K | 42.05%-2M | 46.63%-1.14M |
Operating gains losses | --0 | --0 | ---129.31K | -248.82%-279.59K | ---- | ---- | ---- | ---- | -77.61%187.87K | ---- |
Depreciation and amortization | -26.96%285.64K | 301.07%184.53K | 97.88%151.95K | 114.91%662.44K | 1,118.15%148.59K | 242.21%391.06K | -53.37%46.01K | -7.61%76.79K | 12.35%308.24K | -87.45%12.2K |
Asset impairment expenditure | ---- | ---- | --66.94K | --380.82K | ---- | ---- | ---- | --0 | --0 | ---- |
Remuneration paid in stock | ---- | ---- | ---- | 138.34%858.66K | 138.34%858.66K | ---- | ---- | ---- | 94.44%360.27K | --360.27K |
Deferred tax | ---- | ---- | ---145K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Other non cashItems | 195.82%152.53K | -23.49%61.34K | -25.02%108.32K | -22.35%534.05K | -25.64%468.59K | -349.95%-159.19K | 2,557.31%80.18K | 5,294.61%144.46K | -34.56%687.77K | --630.13K |
Change In working capital | 102.00%4.12K | -181.11%-17.13K | 407.25%233.45K | 50.84%-188.01K | 115.05%72.91K | -399.61%-206.07K | 40.70%21.12K | -159.23%-75.98K | -133.41%-382.41K | -177.36%-484.45K |
-Change in receivables | 63.49%-45.31K | -389.47%-21.16K | -52.30%-8.55K | -331.74%-64.37K | 202.46%69.65K | -1,481.28%-124.08K | 55.75%-4.32K | -104.95%-5.62K | 132.12%27.78K | -2,799.06%-67.98K |
-Change in inventory | ---51 | --6.27K | -85.48%4.68K | 129.62%9.55K | 29.62%-22.7K | --0 | --0 | --32.25K | ---32.25K | ---32.25K |
-Change in prepaid assets | 76.35%14.93K | -41.40%26.36K | 180.12%22.37K | -26.62%19.69K | -12.18%-41.75K | 1,138.77%8.47K | 24.98%44.98K | -72.34%7.98K | 123.76%26.83K | ---37.22K |
-Change in payables and accrued expense | 138.19%34.54K | -46.38%-28.6K | 309.16%231.32K | 74.24%-87.4K | 147.31%133.19K | -91.80%-90.45K | -680.65%-19.54K | -691.65%-110.59K | -435.79%-339.29K | -130.18%-281.52K |
-Change in other working capital | --0 | --0 | ---16.37K | 0.00%-65.48K | ---- | ---- | ---- | ---- | 0.00%-65.48K | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -230.80%-320.65K | 23.96%-152.31K | 297.35%441.05K | 64.01%-302.87K | 150.78%217.86K | -438.13%-96.93K | 49.77%-200.3K | -428.21%-223.49K | 33.78%-841.41K | -163.84%-429.03K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 38.27%-495.22K | 109.13%66.94K | -94.62%-1.16M | -17.13%-2.9M | -40.26%-769.81K | 25.65%-802.21K | -44.24%-732.87K | -75.23%-593.91K | -326.12%-2.47M | -103.18%-548.83K |
Net PPE purchase and sale | --0 | --0 | -115.29%-1.09M | -8.30%-2.6M | -8.10%-738.85K | 31.04%-709.23K | -47.33%-648.9K | -101.69%-505.82K | -361.24%-2.4M | -224.87%-683.5K |
Net business purchase and sale | --0 | 179.72%66.94K | 24.01%-66.94K | -313.73%-296K | -122.99%-30.95K | -84.48%-92.98K | -24.09%-83.97K | 0.05%-88.1K | -19.78%-71.54K | --134.67K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 38.27%-495.22K | 109.13%66.94K | -94.62%-1.16M | -17.13%-2.9M | -40.26%-769.81K | 25.65%-802.21K | -44.24%-732.87K | -75.23%-593.91K | -326.12%-2.47M | -103.18%-548.83K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 9,305.26%1.1M | 91.89%441.54K | -75.57%88.94K | -90.63%364.32K | -1,436.94%-217.82K | -106.76%-12K | -92.50%230.1K | -41.85%364.04K | -19.00%3.89M | 103.39%16.29K |
Net issuance payments of debt | 9,342.76%1.11M | -747.94%-27.97K | -741.55%-11.06K | -37.93%-28.74K | -3.79%-19.74K | -1,883.31%-12K | 813.39%4.32K | -117.19%-1.31K | -100.59%-20.83K | 96.14%-19.02K |
Net common stock issuance | ---19.5K | --469.5K | --100K | -6.11%24K | 100.62%24K | --0 | --0 | --0 | -95.04%25.56K | -377.53%-3.87M |
Proceeds from stock option exercised by employees | --15K | --0 | --0 | -90.50%369.06K | -105.69%-222.08K | --0 | --225.78K | 1,968.54%365.36K | 419.16%3.88M | 377.32%3.9M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 9,305.26%1.1M | 91.89%441.54K | -75.57%88.94K | -90.63%364.32K | -1,436.94%-217.82K | -106.76%-12K | -92.50%230.1K | -41.85%364.04K | -19.00%3.89M | 103.39%16.29K |
Net cash flow | ||||||||||
Beginning cash position | -95.40%108.76K | -96.41%109.61K | -80.08%698.83K | 18.75%3.51M | -66.91%1.48M | -55.61%2.37M | -4.54%3.05M | 18.75%3.51M | 50,155.08%2.95M | 46.90%4.47M |
Current changes in cash | 131.68%288.67K | 150.66%356.17K | -38.06%-625.9K | -595.32%-2.84M | 19.95%-769.76K | -4.40%-911.14K | -132.52%-703.08K | -285.20%-453.36K | -80.58%572.83K | -1,123.38%-961.57K |
Effect of exchange rate changes | -441.19%-82.22K | -2,108.43%-357.02K | 875.76%36.68K | 247.29%27.58K | -497.30%-9.57K | 101.25%24.1K | 160.19%17.78K | -32.40%-4.73K | -1,118.22%-18.72K | 128.91%2.41K |
End cash Position | -78.68%315.21K | -95.40%108.76K | -96.41%109.61K | -80.08%698.83K | -80.08%698.83K | -66.91%1.48M | -55.61%2.37M | -4.54%3.05M | 18.75%3.51M | 18.75%3.51M |
Free cash from | 60.23%-320.65K | 82.06%-152.31K | 11.16%-647.9K | 10.45%-2.91M | 53.17%-521K | 19.37%-806.16K | -1.19%-849.21K | -148.82%-729.31K | -79.44%-3.24M | -350.00%-1.11M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data